US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Contineum Therapeutics, INC.

4.75

+0.600014.46%

Post-market: 4.750.00000.00%16:19 EDT

Volume:67.72K

Turnover:305.68K

Market Cap:122.89M

PE:-2.40

High:4.77

Open:4.16

Low:3.98

Close:4.15

Loading ...

Overview Company News Filings

Discover Real Brokerage And 2 Other Penny Stocks To Watch

Simply Wall St.

Contineum Therapeutics Is Maintained at Overweight by Morgan Stanley

Morgan Stanley Sticks to Their Buy Rating for Contineum Therapeutics, Inc. Class A (CTNM)

Contineum Therapeutics Files $300M Shelf Registration

BRIEF-Contineum Therapeutics Inc Files For Mixed Shelf Of Up To $300 Million

Contineum Therapeutics Inc Files for Mixed Shelf of up to $300 Mln - SEC Filing

THOMSON REUTERS

Contineum Therapeutics Reports Q1 2025 Results: Net Loss Widens to $16M Amid Increased R&D Expenses

Contineum Therapeutics Inc -Cash Runway Projected Through 2027

THOMSON REUTERS

BRIEF-Contineum Therapeutics Appoints Timothy Watkins As Chief Medical Officer And Head Of Development

Contineum Therapeutics Appoints Timothy Watkins, M.d., M.sc., as Chief Medical Officer and Head of Development

THOMSON REUTERS

Contineum Therapeutics Appoints Timothy Watkins, M.D., M.Sc., as Chief Medical Officer and Head of Development

Analysts Are Bullish on Top NA Stocks: Unusual Machines Inc. (UMAC), Contineum Therapeutics, Inc. Class A (CTNM)

Contineum Therapeutics Appoints Diego Miralles to Board

Contineum Therapeutics Announces Appointment of Diego Miralles, M.D. to Its Board of Directors

Buy Rating for Contineum Therapeutics: Promising Pipeline and Market Opportunities

JonesTrading Initiates Contineum Therapeutics at Buy With $23 Price Target

MT Newswires Live

Contineum Therapeutics Inc : Jonestrading Initiates Coverage With Buy Rating; Price Target $23

THOMSON REUTERS

Institutional investors in Contineum Therapeutics, Inc. (NASDAQ:CTNM) have had a wonderful week after share price increased 24%

Simply Wall St.

Contineum price target lowered to $16 from $32 at Baird

Contineum Therapeutics Inc: Cash Runway Projected Through 2027

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CTNM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CTNM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTNM\",,,,,undefined,":{"symbol":"CTNM","market":"US","secType":"STK","nameCN":"Contineum Therapeutics, INC.","latestPrice":4.75,"timestamp":1749240000000,"preClose":4.15,"halted":0,"volume":67719,"hourTrading":{"tag":"盘后","latestPrice":4.75,"preClose":4.75,"latestTime":"16:19 EDT","volume":1185,"amount":5635.65,"timestamp":1749241198526},"delay":0,"floatShares":13167143,"shares":25871549,"eps":-1.975239,"marketStatus":"Market Closed","change":0.6,"latestTime":"06-06 16:00:00 EDT","open":4.16,"high":4.765,"low":3.98,"amount":305680.9423,"amplitude":0.189157,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.975239,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1712289600000,"exchange":"NASDAQ","adjPreClose":4.15,"preHourTrading":{"tag":"盘前","latestPrice":4.19,"preClose":4.15,"latestTime":"09:29 EDT","volume":30,"amount":125.79999,"timestamp":1749216590034},"postHourTrading":{"tag":"盘后","latestPrice":4.75,"preClose":4.75,"latestTime":"16:19 EDT","volume":1185,"amount":5635.65,"timestamp":1749241198526},"volumeRatio":0.36693762911708244,"impliedVol":0.7834,"impliedVolPercentile":0.2195},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTNM\",,,,,undefined,":{"symbol":"CTNM","floatShares":13167143,"roa":"-22.94%","roe":"-33.03%","lyrEps":-2.183553,"volumeRatio":0.36693762911708244,"shares":25871549,"dividePrice":0,"high":4.765,"amplitude":0.189157,"preClose":4.15,"low":3.98,"week52Low":3.35,"pbRate":"0.67","week52High":22,"institutionHeld":0,"latestPrice":4.75,"eps":-1.975239,"divideRate":0,"volume":67719,"delay":0,"ttmEps":-1.975239,"open":4.16,"prevYearClose":14.65,"prevWeekClose":3.66,"prevMonthClose":3.66,"prevQuarterClose":6.98,"fiveDayClose":3.66,"twentyDayClose":3.95,"sixtyDayClose":7.56},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTNM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540003068","title":"Discover Real Brokerage And 2 Other Penny Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2540003068","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540003068?lang=en_us&edition=fundamental","pubTime":"2025-06-04 02:05","pubTimestamp":1748973918,"startTime":"0","endTime":"0","summary":"The market is up 2.0% in the last 7 days, with all sectors gaining ground, and over the past 12 months, it has risen by 12%, with earnings forecasted to grow by 14% annually. For those looking to invest in smaller or newer companies, penny stocks—despite their somewhat outdated name—can still offer surprising value. By focusing on those with robust financials and a clear growth trajectory, investors can find opportunities that may provide both stability and potential upside.The Real Brokerage Inc., with a market cap of US$849.54 million, operates in the real estate technology sector and is experiencing rapid growth, evidenced by its Q1 2025 revenue of US$353.98 million. Despite being unprofitable with increasing losses over the past five years, the company has no debt and maintains a strong cash runway exceeding three years due to positive free cash flow. Recent strategic moves include a share repurchase program up to $150 million and filing for $209.5 million in shelf registration, in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/discover-real-brokerage-2-other-180518987.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4166","DFS","TBTC","BABB","BK4209","LU0106831901.USD","LU1791807156.HKD","LU1668664300.SGD","BK4588","LU1861217088.USD","NRT","BK4213","BK4023","LU2360107671.USD","CTNM","PERF","BK4007","LU1861220207.SGD","BK4585","BK4150"],"gpt_icon":0},{"id":"2536633519","title":"Contineum Therapeutics Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2536633519","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536633519?lang=en_us&edition=fundamental","pubTime":"2025-05-19 22:47","pubTimestamp":1747666020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CTNM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 19, 2025 10:47 ET (14:47 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","CTNM"],"gpt_icon":0},{"id":"2536682394","title":"Morgan Stanley Sticks to Their Buy Rating for Contineum Therapeutics, Inc. Class A (CTNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2536682394","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536682394?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:47","pubTimestamp":1747658852,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Sean Laaman maintained a Buy rating on Contineum Therapeutics, Inc. Class A (CTNM – Research Report) today and set a price t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-their-buy-rating-for-contineum-therapeutics-inc-class-a-ctnm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-their-buy-rating-for-contineum-therapeutics-inc-class-a-ctnm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTNM"],"gpt_icon":0},{"id":"2535688320","title":"Contineum Therapeutics Files $300M Shelf Registration","url":"https://stock-news.laohu8.com/highlight/detail?id=2535688320","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535688320?lang=en_us&edition=fundamental","pubTime":"2025-05-15 05:12","pubTimestamp":1747257121,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics, Inc. Class A ( ($CTNM) ) just unveiled an update. On May 14, 2025, Contineum Therapeutics filed a Shelf Registration Statem...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/contineum-therapeutics-files-300m-shelf-registration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/contineum-therapeutics-files-300m-shelf-registration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LENZ","CTNM","BK4539","BK4139"],"gpt_icon":0},{"id":"2535886018","title":"BRIEF-Contineum Therapeutics Inc Files For Mixed Shelf Of Up To $300 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535886018","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535886018?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:50","pubTimestamp":1747255838,"startTime":"0","endTime":"0","summary":"BRIEF-Contineum Therapeutics Inc Files For Mixed Shelf Of Up To $300 Million May 14 (Reuters) - Contineum Therapeutics Inc CTNM.O:CONTINEUM THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $300 MILLION - SEC FILINGFurther company coverage: CTNM.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nFWN3RM2Z5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"gpt_icon":0},{"id":"2535888873","title":"Contineum Therapeutics Inc Files for Mixed Shelf of up to $300 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2535888873","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535888873?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:42","pubTimestamp":1747255350,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nFWN3RM2Z5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTNM","BK4007"],"gpt_icon":0},{"id":"2535002022","title":"Contineum Therapeutics Reports Q1 2025 Results: Net Loss Widens to $16M Amid Increased R&D Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2535002022","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535002022?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:08","pubTimestamp":1747253312,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Contineum Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL5tvpJH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"gpt_icon":0},{"id":"2535007193","title":"Contineum Therapeutics Inc -Cash Runway Projected Through 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2535007193","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535007193?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:05","pubTimestamp":1747253101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nTUA6LLJB2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CTNM"],"gpt_icon":0},{"id":"2531268647","title":"BRIEF-Contineum Therapeutics Appoints Timothy Watkins As Chief Medical Officer And Head Of Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2531268647","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531268647?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:12","pubTimestamp":1745871134,"startTime":"0","endTime":"0","summary":"BRIEF-Contineum Therapeutics Appoints Timothy Watkins As Chief Medical Officer And Head Of DevelopmentApril 28 (Reuters) - Contineum Therapeutics Inc CTNM.O:CONTINEUM THERAPEUTICS APPOINTS TIMOTHY WAT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nTUA9XXJJ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"gpt_icon":0},{"id":"2531268858","title":"Contineum Therapeutics Appoints Timothy Watkins, M.d., M.sc., as Chief Medical Officer and Head of Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2531268858","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531268858?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:05","pubTimestamp":1745870701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nTUA9XXJJ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTNM","BK4007"],"gpt_icon":0},{"id":"2531608266","title":"Contineum Therapeutics Appoints Timothy Watkins, M.D., M.Sc., as Chief Medical Officer and Head of Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2531608266","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531608266?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:05","pubTimestamp":1745870700,"startTime":"0","endTime":"0","summary":"SAN DIEGO, April 28, 2025----Contineum Therapeutics, Inc.  , a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology  indications, today announced the appointment of Timothy Watkins, M.D., M.Sc., to the Company’s executive team as its Chief Medical Officer and Head of Development. Effective immediately, Dr. Watkins will lead all clinical development and medical affairs activities at Contineum. Dr. Watkins succeeds Stephen L. Huhn, M.D., who has been the Company’s Chief Medical Officer since early 2020. Dr. Huhn will serve as an advisor during the leadership transition.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/contineum-therapeutics-appoints-timothy-watkins-200500814.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0058720904.USD","SQQQ","QLD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","GILD","NVIW.SI","USAW.SI",".IXIC","LU1066051498.USD","BK4139","LU0889565916.HKD","IE00B3T34201.USD","LU1571399168.USD","BK4566","PSQ","BK4588","IE00BKVL7J92.USD","LU0289739699.SGD","BK4550","TQQQ","LU1430594728.SGD","BK4583","LU1066053197.SGD","IE0002270589.USD","CTNM","BK4585","LU2468319806.SGD","LU0234570918.USD","LU2087621335.USD","IE00BZ1G4Q59.USD","USJW.SI","LU0320765992.SGD","IE00B19Z3581.USD","BK4568","BK4532","LU2089984988.USD","IE00B7SZLL34.SGD","TSYW.SI","MNQmain","NQmain","BK4007","LU1839511570.USD","LU0109394709.USD","LU1585245621.USD","LENZ","BK4578","QID"],"gpt_icon":1},{"id":"2523843923","title":"Analysts Are Bullish on Top NA Stocks: Unusual Machines Inc. (UMAC), Contineum Therapeutics, Inc. Class A (CTNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2523843923","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523843923?lang=en_us&edition=fundamental","pubTime":"2025-03-31 22:20","pubTimestamp":1743430809,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 3 analysts just weighed in on Unusual Machines Inc. (UMAC – Research Report), Contineum Th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-na-stocks-unusual-machines-inc-umac-contineum-therapeutics-inc-class-a-ctnm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-na-stocks-unusual-machines-inc-umac-contineum-therapeutics-inc-class-a-ctnm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UMAC","BK4157","NA","CTNM","BK4007","BK4603","BK4141"],"gpt_icon":0},{"id":"2520686073","title":"Contineum Therapeutics Appoints Diego Miralles to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2520686073","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520686073?lang=en_us&edition=fundamental","pubTime":"2025-03-18 04:42","pubTimestamp":1742244169,"startTime":"0","endTime":"0","summary":"An update from Contineum Therapeutics, Inc. Class A ( ($CTNM) ) is now available. On March 14, 2025, Contineum Therapeutics, Inc. appointed Diego M...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/contineum-therapeutics-appoints-diego-miralles-to-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/contineum-therapeutics-appoints-diego-miralles-to-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","CTNM","BK4007","BK4139"],"gpt_icon":0},{"id":"2520688031","title":"Contineum Therapeutics Announces Appointment of Diego Miralles, M.D. to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2520688031","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520688031?lang=en_us&edition=fundamental","pubTime":"2025-03-18 04:05","pubTimestamp":1742241900,"startTime":"0","endTime":"0","summary":"SAN DIEGO, March 17, 2025----Contineum Therapeutics, Inc.  , a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology  indications, today announced the appointment of Diego Miralles, M.D. as a member of its board of directors, effective March 14, 2025.\"We are excited to welcome Diego to our board,\" commented Eef Schimmelpennink, Contineum’s Chairperson. \"He has successfully led the development of novel therapies throughout his distinguished career and has an extensive track record in both early stage research and all stages of clinical development. During his time at Janssen Research, Dr. Miralles was engaged in the development and approval of several important medicines. He is an accomplished life sciences executive and his perspective in guiding life sciences companies will provide our board with valuable insights as we look ahead to key clinical development and operating milestones.\". Contineum Ther","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/contineum-therapeutics-announces-appointment-diego-200500029.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CTNM","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2519785337","title":"Buy Rating for Contineum Therapeutics: Promising Pipeline and Market Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2519785337","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519785337?lang=en_us&edition=fundamental","pubTime":"2025-03-13 22:35","pubTimestamp":1741876532,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics, Inc. Class A (CTNM) has received a new Buy rating, initiated by JonesTrading analyst, Debanjana Chatterjee. Debanjana Chatt...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-contineum-therapeutics-promising-pipeline-and-market-opportunities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-contineum-therapeutics-promising-pipeline-and-market-opportunities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTNM","LENZ"],"gpt_icon":0},{"id":"2519839647","title":"JonesTrading Initiates Contineum Therapeutics at Buy With $23 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2519839647","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519839647?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:47","pubTimestamp":1741870047,"startTime":"0","endTime":"0","summary":"JonesTrading Initiates Contineum Therapeutics at Buy With $23 Price Target","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","CTNM"],"gpt_icon":0},{"id":"2519483675","title":"Contineum Therapeutics Inc : Jonestrading Initiates Coverage With Buy Rating; Price Target $23","url":"https://stock-news.laohu8.com/highlight/detail?id=2519483675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519483675?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:33","pubTimestamp":1741869181,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nFWN3PW12V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CTNM"],"gpt_icon":0},{"id":"2519831653","title":"Institutional investors in Contineum Therapeutics, Inc. (NASDAQ:CTNM) have had a wonderful week after share price increased 24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2519831653","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519831653?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:20","pubTimestamp":1741868429,"startTime":"0","endTime":"0","summary":"Given the large stake in the stock by institutions, Contineum Therapeutics' stock price might be vulnerable to their trading decisions. A total of 11 investors have a majority stake in the company with 51% ownership. Ownership research along with  analyst forecasts data  help provide a good understanding of opportunities in a stock. Every investor in Contineum Therapeutics, Inc.  should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are institutions with 40% ownership. Put another way, the group faces the maximum upside potential .Clearly, institutional investors benefitted the most after the company's market cap rose by US$38m last week.Let's delve deeper into each type of owner of Contineum Therapeutics, beginning with the chart below.What Does The Institutional Ownership Tell Us About Contineum Therapeutics?The definition of an insider can differ slightly between different countries, but","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/institutional-investors-contineum-therapeutics-inc-122029483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TSYW.SI","IE00B3QW5Z07.USD","BK4007",".IXIC","TQQQ","IE00BGHQF748.EUR","PSQ","BK4588","MNQmain","NQmain","USAW.SI","LU2210149790.SGD","NDAQ","BK4112","USJW.SI","LU2210150020.SGD","QLD","NVIW.SI","BK4585","IE00BKPKM429.USD","SQQQ","LU2095319765.USD","CTNM","IE00B64PRP62.GBP","QID"],"gpt_icon":1},{"id":"2517482621","title":"Contineum price target lowered to $16 from $32 at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2517482621","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517482621?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:35","pubTimestamp":1741350950,"startTime":"0","endTime":"0","summary":"Baird lowered the firm’s price target on Contineum (CTNM) to $16 from $32 and keeps an Outperform rating on the shares. The firm said its Phase 2 r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/contineum-price-target-lowered-to-16-from-32-at-baird?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/contineum-price-target-lowered-to-16-from-32-at-baird?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTNM","BK4007"],"gpt_icon":0},{"id":"2517115316","title":"Contineum Therapeutics Inc: Cash Runway Projected Through 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2517115316","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517115316?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:34","pubTimestamp":1741296874,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP1MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTNM","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":44,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTNM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"CTNM","fiscalQuarterEnding":"2025/03","expectedEps":-0.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.62}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTNM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTNM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1741924800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CTNM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CTNM","date":"2025-06-06","current":-2.154621,"percent":0.694545,"low":-16.425726,"twenty":-13.448154,"median":-4.770625,"eighty":17.122563,"high":28.322904,"avg":-1.006749,"sd":13.685568,"marketCap":107366928},"quantilePoints":[{"date":"2024-04-05","current":16.281367,"twenty":16.281367,"median":16.281367,"eighty":16.281367,"marketCap":369912656},{"date":"2024-04-12","current":17.609251,"twenty":16.281367,"median":16.569509,"eighty":16.868158,"marketCap":400082176},{"date":"2024-04-19","current":17.122563,"twenty":16.281367,"median":16.868158,"eighty":17.144685,"marketCap":389024629},{"date":"2024-04-26","current":17.686678,"twenty":16.315104,"median":17.089379,"eighty":17.59819,"marketCap":401841332},{"date":"2024-05-03","current":16.48102,"twenty":16.48102,"median":17.122563,"eighty":17.59819,"marketCap":374448771},{"date":"2024-05-10","current":17.719862,"twenty":16.38147,"median":17.105971,"eighty":17.59819,"marketCap":402595255},{"date":"2024-05-17","current":16.547386,"twenty":16.392531,"median":17.100441,"eighty":17.487579,"marketCap":375956618},{"date":"2024-05-24","current":17.819411,"twenty":16.48102,"median":17.133624,"eighty":17.59819,"marketCap":404857026},{"date":"2024-05-31","current":20.173009,"twenty":16.534113,"median":17.172337,"eighty":17.68889,"marketCap":385849140},{"date":"2024-06-07","current":21.67926,"twenty":16.768608,"median":17.354846,"eighty":18.209439,"marketCap":414659209},{"date":"2024-06-14","current":22.311348,"twenty":16.85046,"median":17.388029,"eighty":20.619504,"marketCap":426749148},{"date":"2024-06-21","current":26.466988,"twenty":16.894704,"median":17.487579,"eighty":21.17897,"marketCap":506234071},{"date":"2024-06-28","current":25.216261,"twenty":16.921251,"median":17.542884,"eighty":21.517876,"marketCap":482311425},{"date":"2024-07-05","current":27.018383,"twenty":16.987617,"median":17.609251,"eighty":21.78147,"marketCap":516780614},{"date":"2024-07-12","current":28.242212,"twenty":17.042923,"median":17.692208,"eighty":22.916538,"marketCap":540188796},{"date":"2024-07-15","current":27.932893,"twenty":17.049559,"median":17.697739,"eighty":23.766494,"marketCap":534272442},{"date":"2024-08-02","current":26.224911,"twenty":17.056196,"median":17.697739,"eighty":24.100021,"marketCap":501603882},{"date":"2024-08-09","current":22.338245,"twenty":17.08938,"median":17.819411,"eighty":24.409341,"marketCap":427263614},{"date":"2024-08-16","current":-15.206885,"twenty":17.023013,"median":17.769636,"eighty":24.100021,"marketCap":478195700},{"date":"2024-08-23","current":-14.92058,"twenty":16.547386,"median":17.697739,"eighty":23.683112,"marketCap":469192554},{"date":"2024-08-30","current":-15.468649,"twenty":16.315104,"median":17.614781,"eighty":23.293101,"marketCap":486427149},{"date":"2024-09-06","current":-14.511573,"twenty":15.417858,"median":17.570537,"eighty":22.830467,"marketCap":456330916},{"date":"2024-09-13","current":-14.765157,"twenty":-14.025672,"median":17.410151,"eighty":22.682531,"marketCap":464305131},{"date":"2024-09-20","current":-16.425726,"twenty":-14.408503,"median":17.365907,"eighty":22.459283,"marketCap":516523382},{"date":"2024-09-27","current":-15.272326,"twenty":-14.745525,"median":17.19999,"eighty":22.405488,"marketCap":480253562},{"date":"2024-10-04","current":-14.421591,"twenty":-14.887859,"median":17.133624,"eighty":22.351694,"marketCap":453501355},{"date":"2024-10-11","current":-13.521775,"twenty":-14.788061,"median":17.100441,"eighty":22.316727,"marketCap":425205752},{"date":"2024-10-18","current":-13.480875,"twenty":-14.745525,"median":17.039604,"eighty":22.010098,"marketCap":423919588},{"date":"2024-10-25","current":-13.309092,"twenty":-14.662087,"median":16.868158,"eighty":21.934785,"marketCap":418517700},{"date":"2024-10-31","current":-14.004404,"twenty":-14.595828,"median":16.547386,"eighty":21.78147,"marketCap":440382485},{"date":"2024-11-08","current":-13.455721,"twenty":-14.532841,"median":16.387,"eighty":21.655052,"marketCap":477166769},{"date":"2024-11-15","current":-13.193473,"twenty":-14.477216,"median":16.281367,"eighty":21.566291,"marketCap":467866942},{"date":"2024-11-22","current":-10.423934,"twenty":-14.434679,"median":15.167037,"eighty":21.517876,"marketCap":369653551},{"date":"2024-11-29","current":-10.838275,"twenty":-14.411775,"median":-9.795154,"eighty":21.388769,"marketCap":384346893},{"date":"2024-12-06","current":-10.358512,"twenty":-14.347406,"median":-10.271282,"eighty":21.17897,"marketCap":367333550},{"date":"2024-12-13","current":-10.031401,"twenty":-14.270231,"median":-10.358512,"eighty":21.154762,"marketCap":355733543},{"date":"2024-12-20","current":-9.70429,"twenty":-14.217087,"median":-10.242206,"eighty":20.950342,"marketCap":344133536},{"date":"2024-12-27","current":-10.569317,"twenty":-14.14183,"median":-10.271282,"eighty":20.635643,"marketCap":374809110},{"date":"2025-01-03","current":-10.525702,"twenty":-14.135286,"median":-10.358512,"eighty":20.603366,"marketCap":373262442},{"date":"2025-01-10","current":-9.718828,"twenty":-14.073857,"median":-10.358512,"eighty":20.25908,"marketCap":344649092},{"date":"2025-01-17","current":-9.071876,"twenty":-14.047944,"median":-10.256744,"eighty":19.850241,"marketCap":321706856},{"date":"2025-01-24","current":-8.19958,"twenty":-14.045305,"median":-10.209494,"eighty":18.599466,"marketCap":290773505},{"date":"2025-01-31","current":-7.429052,"twenty":-14.035488,"median":-10.009594,"eighty":17.759682,"marketCap":263449044},{"date":"2025-02-07","current":-6.883867,"twenty":-14.024036,"median":-9.925999,"eighty":17.706588,"marketCap":244115699},{"date":"2025-02-14","current":-5.589962,"twenty":-14.010948,"median":-9.718828,"eighty":17.697739,"marketCap":198231228},{"date":"2025-02-21","current":-5.742614,"twenty":-13.988044,"median":-9.667944,"eighty":17.693315,"marketCap":203644564},{"date":"2025-02-28","current":-5.19016,"twenty":-13.940599,"median":-9.518928,"eighty":17.660132,"marketCap":184053442},{"date":"2025-03-07","current":-3.942751,"twenty":-13.847345,"median":-9.071876,"eighty":17.615888,"marketCap":166612775},{"date":"2025-03-14","current":-4.371311,"twenty":-13.716463,"median":-8.19958,"eighty":17.604827,"marketCap":184722859},{"date":"2025-03-21","current":-4.377433,"twenty":-13.63957,"median":-8.126889,"eighty":17.576068,"marketCap":184981575},{"date":"2025-03-28","current":-4.561102,"twenty":-13.619937,"median":-7.567165,"eighty":17.520762,"marketCap":192743040},{"date":"2025-04-04","current":-3.75296,"twenty":-13.617995,"median":-7.116479,"eighty":17.456608,"marketCap":158592595},{"date":"2025-04-11","current":-2.528503,"twenty":-13.600664,"median":-6.847522,"eighty":17.401302,"marketCap":106849497},{"date":"2025-04-17","current":-2.681561,"twenty":-13.574128,"median":-6.436815,"eighty":17.385817,"marketCap":113317384},{"date":"2025-04-25","current":-2.767272,"twenty":-13.55286,"median":-5.742614,"eighty":17.372544,"marketCap":116939401},{"date":"2025-05-02","current":-2.430547,"twenty":-13.541408,"median":-5.640845,"eighty":17.334936,"marketCap":102710049},{"date":"2025-05-09","current":-2.418302,"twenty":-13.513595,"median":-5.553616,"eighty":17.244235,"marketCap":102192618},{"date":"2025-05-16","current":-2.045592,"twenty":-13.477603,"median":-5.430041,"eighty":17.188929,"marketCap":101933903},{"date":"2025-05-23","current":-2.030017,"twenty":-13.462755,"median":-5.321004,"eighty":17.144685,"marketCap":101157756},{"date":"2025-05-30","current":-1.853493,"twenty":-13.455721,"median":-5.117468,"eighty":17.144685,"marketCap":92361429},{"date":"2025-06-06","current":-2.154621,"twenty":-13.448154,"median":-4.770625,"eighty":17.122563,"marketCap":107366928}],"updateTime":1749375908422}}}